Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Biotech
Tortugas comes out of shell with $106M, 4 ph. 2-stage neuro meds
A pair of Sage veterans has launched a neurology startup armed with $106 million and a clinical-stage pipeline licensed from Eisai and Hansoh.
James Waldron
Apr 21, 2026 10:41am
NIH instability grows with exit of longtime neuro director
Jan 2, 2026 2:16pm
FDA approves 1st nondrug, at-home treatment for depression
Dec 11, 2025 6:00am
Beacon Biosignals aglow with $86M neurodiagnostic fundraising
Nov 17, 2025 9:25am
Angelini signs $550M-plus neuro pact with South Korean biotech
Sep 22, 2025 1:47pm
Fierce Pharma
AbbVie will continue to pursue external innovation for long-term
Jul 31, 2025 11:44am